Arkuda Therapeutics is based in Watertown. It has raised $64M in total funding. Latest round: Series B.
Arkuda Therapeutics is based in Watertown. Arkuda Therapeutics has raised $64M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in February 2022. The round record for Arkuda Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Atlas Venture, Eli Lilly and Company, Pfizer Ventures, Cormorant Asset Management, Pivotal Life Sciences, Surveyor Capital. 6 distinct backers are named across the disclosed rounds.
Every Arkuda Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Watertown at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026